Sherbrooke Park Advisers LLC Maravai Lifesciences Holdings, Inc. Transaction History
Sherbrooke Park Advisers LLC
- $215 Billion
- Q1 2025
A detailed history of Sherbrooke Park Advisers LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 13,168 shares of MRVI stock, worth $25,809. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,168
Previous 14,358
8.29%
Holding current value
$25,809
Previous $78.3 Million
62.81%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding MRVI
# of Institutions
207Shares Held
129MCall Options Held
267KPut Options Held
648K-
Gtcr LLC20.2MShares$39.5 Million4.99% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$24.5 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$22.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$19.1 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$16.4 Million1.13% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $258M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...